Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients

Journal of Interventional Cardiology

Volumn 31, Issue 2, 2018, Pages 144-149

  Bayramoğlu, Adil ^a   Taşolar, Hakan ^b   Kaya, Ahmet ^a   Tanboğa, İbrahim Halil ^c   Yaman, Mehmet ^a   Bektaş, Osman ^a   Günaydın, Zeki Yüksel ^a   Oduncu, Vecih ^d  

^a ORDU UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

^c Hisar Hospital Intercontinental   (Turkey)

^d BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

new scoring system; no reflow; ST segment elevation myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATIONAL STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS; VALIDATION PROCESS; AGE; CLASSIFICATION; COMPLICATION; METHODOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; STENT; TURKEY (BIRD);

AGE FACTORS; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; ST ELEVATION MYOCARDIAL INFARCTION; STENTS; TURKEY;

EID: 85045303837     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/joic.12463     Document Type: Article

References (25)

1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993; 329:1615–1622.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361:13–20.
3. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008; 72:950–957.
4. Beaglehole R, Irwin A, Prentice T. The World Health Report 2004: Changing History. Geneva: World Health Organization, 2004.
5. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation. 1994; 89:2514–2518.
6. Sabin P, Koshy AG, Gupta PN, et al. Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. Indian Heart J. 2017; 69 34–45.
7. Yesin M, Çağdaş M, Kalçık M, et al. Comparison of syntax score and syntax score II to predict “no reflow phenomenon” in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging. 2017; 17:1200–1205
8. Wang JW, Zhou ZQ, Chen YD, et al. A risk score for no-reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Clin Cardiol. 2015; 38:208–221
9. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med. 1985 312:932–936.
10. Gibson CM, Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001; 103:2550–2554.
11. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to longterm outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002; 105:1909–1913.
12. Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008; 72:716–721.
13. Şahin DY, Gür M, Elbasan Z, et al. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis. 2013; 24: 148–153.
14. Magro M, Nauta ST, Simsek C, et al. Usefulness of the SYNTAX score to predict ‘no-reflow’ in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2012; 109:601–606.
15. Akgun T, Oduncu V, Bitigen A, et al. Baseline SYNTAX score and long-term outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Appl Thromb Hemost. 2015 21: 712–719.
16. Jaffe R, Charron T, Puley G, et al. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008; 117:3152–3156.
17. Izgi A, Kirma C, Tanalp AC, et al. Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous coronary interventions. Coron Artery Dis. 2007; 18: 443–449.
18. Liang T, Liu M, Wu C, et al. Risk factors for no-reflow phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. Rev Invest Clin. 2017; 69: 139–145.
19. Balta S, Celik T, Ozturk C, et al. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevationmyocardial infarction. Am J Emerg Med. 2016; 34:1542–1547.
20. Wang L, Liu G, Liu J, et al. Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention. Ther Clin Risk Manag. 2016; 12:1017–1022.
21. Lim S, Koh YS, Kim PJ, et al. Incidence, implications, and predictors of stent thrombosis in Acute Myocardial Infarction. Am J Cardiol. 2016; 117:1562–1568.
22. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest. 2002; 122:1322–1332.
23. Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010; 55:2383–2389.
24. Fearon WF, Shah M Ng M, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008; 51:560–565.
25. 2-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with Acute Coronary Syndrome: data from Taiwan Acute Coronary Syndrome Full Spectrum Registry. PLoS ONE. 2014; 9:e111167.